Tag: AT-1001

Browse all articles tagged with “AT-1001”.

1 article

Larazotide: The Tight Junction Regulator Peptide in Phase 3 Celiac Disease Trials

A comprehensive research overview of larazotide (AT-1001), the synthetic peptide tight junction regulator that has advanced to Phase 3 clinical trials for celiac disease, examining its unique mechanism of restoring intestinal barrier function.

2026-02-01·14 min read

LarazotideAT-1001tight junctionceliac diseasegut barrierzonulinintestinal permeability

←Back to blog

For informational purposes only. Not medical advice. Always consult with qualified healthcare professionals.